Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Net Change in Cash

Amneal Pharmaceuticals Inc Net Change in Cash Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Net Change in Cash from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Net Change in Cash for the quarter ending December 12, 2018 was $47m a 154.32% increase of 72m year over year
  • Amneal Pharmaceuticals Inc Net Change in Cash for the last 12 months ending December 12, 2018 was $141m a 97.37% increase of 137m year over year
  • Amneal Pharmaceuticals Inc Annual Net Change in Cash for 2018 was $141m a 66.78% increase of 94m from 2017
  • Amneal Pharmaceuticals Inc Annual Net Change in Cash for 2017 was $47m a 172.05% increase of 81m from 2016
  • Amneal Pharmaceuticals Inc Annual Net Change in Cash for 2016 was $-34m a -67.36% increase of 23m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Net Change in Cash Data

12/2018$47m
09/2018$104m
06/2018$16m
03/2018$-25m
12/2017$55m
09/2017$-30m
06/2017$-3m
03/2017$18m
12/2016$-9m

Annual AMRX Net Change in Cash Data

2018$141m
2017$47m
2016$-34m
2015$-56m
2014$36m